Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: epublish

Résumé

[This corrects the article DOI: 10.1016/j.gore.2019.100532.].

Identifiants

DOI: 10.1016/j.gore.2020.100590 PMID: 32885014 PMC: PMC7452617
pubmed: 32885014
doi: 10.1016/j.gore.2020.100590
pii: S2352-5789(20)30056-4
pii: 100590
pmc: PMC7452617
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

100590

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Commentaires et corrections

Type : ErratumFor

Informations de copyright

© 2020 The Author(s).

Auteurs

Alessandro D Santin (AD)

Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06520, USA.

Virginia Filiaci (V)

NRG Oncology Statistical and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Stefania Bellone (S)

Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06520, USA.

Roisin O'Cearbhaill (R)

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

Elena S Ratner (ES)

Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06520, USA.

Cara A Mathews (CA)

Medical Oncology, Women & Infants Hospital, 101 Dudley Street, Providence, RI 02905, USA.

Guilherme Cantuaria (G)

Gynecologic Oncology, 980 Johnson Ferry Road #910, Atlanta, GA 30342, USA.

Camille C Gunderson (CC)

Department of Obstetrics & Gynecology, University of Oklahoma, The Stephenson Cancer Center, 800 NE 10th Street, Suite 2500, Oklahoma City, OK 73104, USA.

Teresa Rutledge (T)

Gynecologic Oncology, University of New Mexico, 1201 Camino de Salud, Albuquerque, NM 87102, USA.

Barbara M Buttin (BM)

Department of Obstetrics & Gynecology, Northwestern Medicine Regional Medical Group, 4405 Weaver Parkway, Warrenville, IL 60555-3269, USA.

Heather A Lankes (HA)

NRG Oncology, Operations Center-Philadelphia East, Philadelphia, PA, USA.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Michael J Birrer (MJ)

Division of Hematology/Oncology, O'Neal Cancer Center University of Alabama, 176F 10390, 619 19th Street S, Birmingham, AL, USA.

Classifications MeSH